ACS Study Quantifies Financial Burden of Cancer in Older Patients
A study published in the Journal of the National Cancer Institute quantifies the financial burden of cancer treatment on patients aged 66 and older. Findings indicate that costs are highest during the end-of-life phase, emphasizing the need for better alignment between treatment intensity and patient goals.
Why it matters
The research provides essential data for policymakers and healthcare providers to improve the cost-effectiveness and quality of cancer care for the elderly.
Costs from treatments and medical services for older adults (66 years and older) with cancer vary significantly by a number of factors, including cancer type and stage, but rising costs tended to impact patients most in the end-of-life stage of care, according to findings from a study published in the Journal of the National Cancer Institute .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in